SNDK arrives at its August 5 earnings release having lost nearly half its value in a month, with a short base at its highest point in the rebuilding cycle and a Street consensus that still implies the stock is worth twice what the market is currently paying.
The week's most significant positioning shift is in options. The put/call ratio dropped sharply to 1.32 on Tuesday — more than two standard deviations below its 20-day average of 1.51. That's a striking collapse in what had been a structurally defensive setup. Historically, a sharp PCR decline of this magnitude into a falling stock tends to reflect put holders closing positions rather than new bulls entering. The short base, by contrast, has kept building. SI climbed 20% over the week to 8.4 million shares, or 5.73% of the free float — the highest in the current rebuilding cycle and meaningfully above where the new cohort of shorts began re-establishing after the original June position was covered. Borrow cost spiked 322% on the week to 0.35%, the biggest single-week move in the 30-day window. Yet that number still sits at a low absolute level. Availability remains enormous at 3,657% of short interest — roughly 36 lendable shares for every one borrowed — so the market is not generating squeeze pressure. Bears are paying almost nothing, and there is no friction forcing them out.
The analyst picture is where the tension becomes almost surreal. The mean Street price target is $2,218, implying roughly 100% upside from Tuesday's $1,096 close. The most recent moves are mixed in direction. Susquehanna trimmed its target from $3,250 to $3,050 last week while keeping its Positive rating. Wells Fargo, by contrast, raised its target from $1,250 to $1,620 — still below where SNDK was trading just three weeks ago. The bulls cite a vertically integrated NAND model, Kioxia partnership depth, and EPS growth running at 84% year-on-year. The bears counter with structural NAND oversupply risk, concentrated supplier dependency, and a valuation that — even after the collapse — the market may not yet consider cheap. The PE multiple has contracted 11 points over the past 30 days to 4.6x, reflecting how fast the repricing has moved. The EV/EBITDA of 4.2x is down nearly 4 points over the same window. Cheapening fast does not mean cheap enough — and the wide analyst-to-market gap says no one has yet agreed where the floor is.
Institutional ownership gives some structural context. FMR (Fidelity) holds 8.9% of shares, BlackRock 7.0%, and Vanguard combined approaches 8.9%. Both BlackRock and State Street added to positions through June 30. These are passive and near-passive flows. The insider picture is cleaner in its message: the CLO, CTO, and CEO all sold shares between May and July 1, at prices ranging from $1,479 to $2,184. Those trades happened well above current levels. The CTO's aggregate June sales alone totalled over $3.5 million at prices between $1,757 and $1,758. No insider buying has appeared in the reported window.
The two previous earnings prints provide the most useful frame for what August 5 might look like as a vol event. SNDK gained 11.5% the day after its April 30 Q1 release and extended to +25.9% over five days. The prior quarter saw a 9.4% next-day gain and a 40.7% five-day move. Both prints were rewarded. The setup now is categorically different: then the stock was rallying into earnings; now it is arriving in a 48% drawdown with a rebuilding short base and a collapsed options skew. The question August 5 will answer is whether the earnings result confirms the market's repricing or contradicts it — and the gap between the $1,096 price and the $2,218 analyst consensus means either outcome has a long way to travel.
The week ahead turns entirely on the August 5 print and whether forward guidance on NAND pricing gives the Street a reason to close — or widen — the gap between where analysts think the stock belongs and where the market has decided to put it.
See the live data behind this article on ORTEX.
Open SNDK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
